Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus

Behavioural Pharmacology

Volumn 8, Issue 5, 1997, Pages 442-457

  Weiner, I ^a   Bernasconi, E ^b   Broersen, L M ^b,c   Feldon, J ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b ETH ZURICH   (Switzerland)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Amphetamine; Dopamine; Latent inhibition; Rat; Schizophrenia; Stimulus; Switching

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT;

ANIMAL; ANIMAL BEHAVIOR; ARTICLE; CONDITIONING; DRUG EFFECT; FEMALE; MALE; PSYCHOLOGY; RAT; WISTAR RAT;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); FEMALE; MALE; RATS; RATS, WISTAR; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0031240639     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199710000-00008     Document Type: Article

References (47)

1. Baruch I, Hemsley D and Gray JA (1988a) Differential performance of acute and chronic schizophrenics in a latent inhibition task. Journal of Nervous and Mental Disease, 176, 598-606.
2. Baruch I, Hemsley DR and Gray JA (1988b) Latent inhibition and 'psychotic proneness' in normal subjects. Personality and Individual Differences, 9, 777-783.
3. Christison GW, Atwater GE, Dunn LA and Kilts CD (1988) Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biological Psychiatry, 23, 746-749.
4. De la Casa LG, Ruiz G and Lubow RE (1993a) Amphetamine-produced attenuation of latent inhibition is modulated by stimulus pre-exposure duration: implications for schizophrenia. Biological Psychiatry, 33, 707-711.
5. De la Casa LG, Ruiz G and Lubow RE (1993b) Latent inhibition and recall/recognition of irrelevant stimuli as a function of pre-exposure duration in high and low psychotic-prone normals. British Journal of Psychology, 84, 119-132.
6. Dunn LA and Scibilia RJ (1996) Reaction time and pupil response measures show reduced latent inhibition in chronic schizophrenia. Society for Neuroscience Abstracts, 22, 239.
7. Dunn LA, Atwater GE and Kilts CD (1993) Effects of antipsychotic drugs on latent inhibition-sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology, 112, 315-323.
8. Feldon J and Weiner I (1991a) An animal model of attention deficit. In: Neuromethods, Vol. 18: Animal Models in Psychiatry I. (Eds AA Boulton, GB Baker and MT Martin-Iverson), pp. 313-361. Humana Press, Clifton, New Jersey.
9. Feldon J and Weiner I (1991b) The latent inhibition model of schizophrenic attention disorder: haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli. Biological Psychiatry, 29, 635-646.
10. Feldon J and Weiner I (1992) From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. Journal of Psychiatric Research, 26, 345-366.
11. Gray JA, Feldon J, Rawlins JNP, Hemsley DR and Smith AD (1991) The neuropsychology of schizophrenia. Behavioral and Brain Sciences, 14, 1-84.
12. Gray JA, Joseph MH, Hemsley DR, Young AMJ, Warburton EC, Boulenguez P, Grigoryan GA, Peters SL, Rawlins JNP, Taib C-T et al. (1995) The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. Behavioural Brain Research, 71, 19-31.
13. Gray JA, Moran PM, Grigoryan G, Peters SL, Young AMJ and Joseph MH (1997) Latent inhibition: the nucleus accumbens connection revisited. Behavioural Brain Research, in press.
14. Gray NS, Hemsley DR and Gray JA (1992a) Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurology, Psychiatry and Brain Research, 1, 83-89.
15. Gray NS, Pickering AD, Hemsley DR, Dawling S and Gray JA (1992b) Abolition of latent inhibition by a single 5 mg dose of D-amphetamine in man. Psychopharmacology, 107, 425-430.
16. 2 binding using SPET. Schizophrenia Research, 17, 95-107.
17. Hall G (1991) Perceptual and Associative Learning. Oxford University Press, New York.
18. Killcross AS and Robbins TW (1993) Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology, 110, 479-489.
19. Killcross AS, Dickinson A and Robbins TW (1994) Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction. Psychopharmacology, 115, 185-195.
20. Lipp OV and Vaitl D (1992) Latent inhibition in human Pavlovian differential conditioning: effect of additional stimulation after pre-exposure and relation to schizotypal traits. Personality and Individual Differences, 13, 1003-1012.
21. Lubow RE (1973) Latent inhibition. Psychological Bulletin, 79, 398-407.
22. Lubow RE (1989) Latent Inhibition and Conditioned Attention Theory. Cambridge University Press, Cambridge.
23. Lubow RE and Gewirtz JC (1995) Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychological Bulletin, 117, 87-103.
24. Lubow RE, Weiner I and Schnur P (1981) Conditioned attention theory. In: The Psychology of Learning and Motivation, Vol. 15. (Ed. GH Bower), pp. 1-49. Academic Press, New York.
25. Lubow RE, Ingberg-Sachs Y, Zalstein-Orda N and Gewirtz JC (1992) Latent inhibition in low and high "psychotic-prone" subjects. Personality and Individual Differences, 13, 563-572.
26. Mackintosh NJ (1975) A theory of attention: variations in the associability of stimuli with reinforcement. Psychological Review, 82, 276-298.
27. Mackintosh NJ (1983) Conditioning and Associative Learning. Oxford University Press, New York.
28. Moore JW and Stickney KJ (1980) Formation of attentional-associative networks in real time: role of the hippocampus and implications for conditioning. Physiological Psychology, 8, 207-217.
29. Robbins TW (1990) The case for frontostriatal dysfunction in schizophrenia. Schizophrenia Bulletin, 16, 391-402.
30. Ruob C, Elsner J, Weiner I and Feldon J (1997) Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus. Behavioural Brain Research, in press.
31. Schmajuk NA and Moore JW (1985) Real-time attentional models for classical conditioning and the hippocampus. Physiological Psychology, 13, 278-290.
32. Schmajuk NA and Moore JW (1988) The hippocampus and the classically conditioned nictitating membrane response: a real-time attentional-associative model. Psychobiology, 16, 20-35.
33. Solomon PR and Staton DM (1982) Differential effects of microinjections of D-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biological Psychiatry, 17, 743-756.
34. Solomon PR, Crider A, Winkelman JW, Turi A, Kamer RM and Kaplan LJ (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biological Psychiatry, 16, 519-537.
35. Swerdlow NR, Braff DL, Hartston H, Perry W and Geyer MA (1996) Latent inhibition in schizophrenia. Schizophrenia Research, 20, 91-103.
36. Thornton JC, Dawe S, Lee C, Capstick C, Corr PJ, Cotter P, Frangou S, Gray NS, Russell MAH and Gray JA (1996) Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology, 127, 164-173.
37. Vaitl D and Lipp OV (1997) Latent inhibition and autonomie responses: A psycholophysiological approach. Behavioral Brain Research, in press.
38. Weiner I (1990) Neural substrates of latent inhibition: The switching model. Psychological Bulletin, 108, 442-461.
39. Weiner I and Feldon J (1987) Facilitation of latent inhibition by haloperidol in rats. Psychopharmacology, 91, 248-253.
40. Weiner I and Feldon J (1997) The switching model of latent inhibition: An update of neural substrates. Behavioural Brain Research, in press.
41. Weiner I, Lubow RE and Feldon J (1981) Chronic amphetamine and latent inhibition. Behavioural Brain Research, 2, 285-286.
42. Weiner I, Lubow RE and Feldon J (1984) Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology, 83, 194-199.
43. Weiner I, Feldon J and Katz Y (1987) Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats. Pharmacology Biochemistry and Behavior, 26, 241-246.
44. Weiner I, Lubow RE and Feldon J (1988) Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacology, Biochemistry and Behavior, 30, 871-878.
45. Weiner I, Shadach E, Tarrasch R, Kidron R and Feldon J (1996) The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine. Biological Psychiatry, 40, 834-843.
46. Weiner I, Shadach E, Barkai R and Feldon J (1997a) Haloperidol and clozapine-induced enhancement of latent inhibition with extended conditioning: Implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology, in press.
47. Weiner I, Tarrasch R, Bernasconi E, Broersen LM, Rüttimann TC and Feldon J (1997b) Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. Pharmacology Biochemistry and Behavior, in press.